ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Gravity-Tolerant In-Flight 3D Bioprinting Enabled by Stereolithography for Space Tissue Engineering.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Growing efforts toward long-duration human space missions demand novel strategies for the treatment of acute injuries in extreme environments. Technologies for space applications must perform reliably even under environmental stressors rarely encountered on Earth, such as gravitational fluctuations. However, space-compatible personalized therapy approaches for treatment of high-risk injuries remain scarce. 3D bioprinting represents an advanced technology with promising potential to address this unmet medical need by enabling the on-demand fabrication of patient-specific tissue constructs for regenerative wound care. Here, the robust 3D printing of both acellular and cell-laden hydrogel constructs is demonstrated using photo- and bioinks under diverse environmental conditions, including microgravity and hypergravity phases encountered during parabolic flight (0-1.8 g). Despite dynamic accelerative conditions, the developed flight-compliant, closed stereolithographic (SLA) bioprinting system successfully printed 3D structures with maintained dimensional fidelity. Irrespective of gravitational forces, high cell viability was preserved in both fibroblast- and keratinocyte-laden constructs. High-resolution features are achieved with precision comparable to normal-gravity controls. Complex architectures, including gyroids, can be fabricated with smooth, continuous surfaces. These findings establish SLA bioprinting as a robust and gravity-tolerant platform for fabricating viable, cell-laden constructs-offering a promising pathway for advancing tissue engineering in space and in extreme conditions on Earth.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.